Deep Dive: Deep Dive Into Biosimilars

Although equally effective and less expensive than reference products, biosimilars continue to face substantial challenges limiting its uptake among providers and patients. Dr. Sameer Awsare, MD, FACP, associate executive director for The Permanente Medical Group, addresses the current state of biosimilar uptake in the United States and his predictions for the near future.